President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
Shares of Sarepta sank 36% before the bell on Tuesday after a trial for two gene-targeted therapies for a muscle-wasting ...
George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...
21hon MSN
FDA’s top drug regulator resigns after federal officials probe ‘serious concerns’ about his conduct
Dr. George Tidmarsh, the head of the Food and Drug Administration’s drug center, abruptly resigned Sunday amid concerns about ...
(Reuters) -The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, ...
Sarepta said on Monday that its late-stage study testing two gene-targeted therapies for Duchenne muscular dystrophy did not ...
HealthDay on MSN
Top FDA Drug Chief Resigns While Under Investigation
Key Takeaways Dr. George Tidmarsh resigned Sunday while under investigationTidmarsh says he was targeted after questioning a ...
The top drug regulator at the Food and Drug Administration (FDA) resigned Sunday, according to officials, after being accused ...
It was the latest shockwave to sweep through an agency beset by all kinds of tumult in recent months. In interviews, ...
The official, Dr. George F. Tidmarsh, a top regulator at the agency, said disagreements over a new program to rapidly approve medications had caused tensions with agency officials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback